Ko Woon Kim Selected Research

Ko Woon Kim Research Topics

11	Cognitive Dysfunction 12/2022 - 01/2018
7	Alzheimer Disease (Alzheimer's Disease) 12/2022 - 01/2018
3	Dementia (Dementias) 04/2024 - 12/2022
3	Cerebral Small Vessel Diseases 06/2019 - 10/2017
1	Neuroinflammatory Diseases 04/2024
1	Genetic Risk Score 12/2022
1	Leukoaraiosis 11/2020
1	Primary Progressive Aphasia 01/2020
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2020
1	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 06/2019
1	Cerebral Cortical Thinning 01/2018
1	Atrophy 01/2018
1	Normal Pressure Hydrocephalus 01/2018
1	Ischemia 01/2018
1	Mixed Dementias 01/2017

10	Amyloid (Amyloid Fibrils)IBA 12/2022 - 10/2017
4	Apolipoproteins E (ApoE)IBA 12/2022 - 01/2018
3	Biomarkers (Surrogate Marker)IBA 04/2024 - 01/2019
2	7- (6- fluoropyridin- 3- yl)- 5H- pyrido(4,3- b)indoleIBA 01/2020 - 01/2018
2	4- (N- methylamino)- 4'- (2- (2- (2- fluoroethoxy)ethoxy)ethoxy)stilbeneIBA 01/2020 - 01/2018
2	ApolipoproteinsIBA 01/2020 - 01/2018
2	Apolipoprotein E4IBA 01/2020 - 01/2018
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2024
1	NucleotidesIBA 12/2022
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 09/2022
1	Donepezil (Aricept)FDA LinkGeneric 09/2022
1	Amyloid beta-PeptidesIBA 01/2021
1	CateninsIBA 11/2020
1	5- aminocarbonyl- 10,11- dihydro- 5H- dibenzo(a,d)cyclohepten- 5,10- imine (ADCI)IBA 01/2020
1	florbetapirIBA 01/2020
1	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 01/2017

1	Therapeutics 04/2024